Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

The XBB.1.5 subvariant — nicknamed ‘Kraken ... and how the PBS NewsHour covered them. After a year, omicron still driving COVID surges amid holiday season The omicron variant is driving ...

The CDC has just announced a second shot for elders and the immunocompromised people – but when’s the best time?

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

A new variant of COVID called XEC — a combination of two Omicron subvariants — is spreading in the middle of flu season.

1, which is a subvariant of omicron ... examining COVID-19 infections, hospitalizations, and deaths in Nebraska after vaccination with the 2023-2024 vaccines that targeted the XBB.1.5 variant ...

Even though these clinics are no longer around, COVID-19 vaccines can be found at select pharmacies ... replaces the previous ...

There are a number of questions surrounding the new procurement of coronavirus vaccines in Hungary. The country is currently ...

Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA ...

Updated COVID-19 vaccines targeting JN ... 1-lineage variants of omicron rather than the XBB.1.5 omicron variant. This is akin to a strain change for a seasonal influenza vaccine.